Overall survival (A,C) and progression-free survival (B,D) of patients with peripheral T-cell lymphoma.

(A,B) Patients with high nm23-H1 (≥ 12.01 ng/mL; n = 45) had a worse prognosis than patients with low nm23-H1 (< 12.01 ng/mL; n =18). (C,D) Patients with high nm23-H1 (≥ 80 ng/mL; n = 16) had a worse prognosis than patients with low nm23-H1 (< 80 ng/mL; n = 47).